AA
PCYC

ALPS Advisors’s PHARMACYCLICS INC PCYC Stock Holding History

ALPS Advisors’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,674
Closed -$509K – 752
2014
Q2 		$509K Buy
5,674
+874
+18% +$82K ﹤0.01% 520
2014
Q1 		$481K Buy
+4,800
New +$624K ﹤0.01% 549

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ALPS Advisors's PCYC Position: Q3 2014 in Review

ALPS Advisors sold out of PHARMACYCLICS INC (PCYC) in Q3 2014, closing a stake of 5,674 shares — an estimated $509K sold.

ALPS Advisors first reported a position in PCYC in Q1 2014 and held it in 2 quarters. The position peaked at $509K in Q2 2014. 250 funds tracked by Wall St. Rank hold PCYC as of Q3 2014.

  • ALPS Advisors reported no remaining PHARMACYCLICS INC position as of Q3 2014 after selling out during the quarter.
  • ALPS Advisors sold 5,674 PHARMACYCLICS INC shares in Q3 2014, an estimated $509K.
  • ALPS Advisors first reported a position in PHARMACYCLICS INC in Q1 2014 and held it in 2 quarters.
  • ALPS Advisors's PHARMACYCLICS INC position peaked at $509K in Q2 2014.
  • 250 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q3 2014.

Based on ALPS Advisors's 13F filing for Q3 2014, filed 24 Nov 2014.